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Abstract 
Poorly water-soluble drugs are a significant and ongoing issue for the pharmaceutical 
industry. An overview of recent developments for the preparation of spray-dried delivery 
systems is presented. Examples include amorphous solid dispersions, spray dried dispersions, 
microparticles, nanoparticles, surfactant systems and self-emulsifying drug delivery systems. 
Several aspects of formulation are considered, such as pre-screening, choosing excipient(s), 
the effect of polymer structure on performance, formulation optimisation, ternary dispersions, 
fixed-dose combinations, solvent selection and component miscibility. Process optimisation 
techniques including nozzle selection are discussed. Comparisons are drawn with other 
preparation techniques such as hot melt extrusion, freeze drying, milling, electro spinning and 
film casting. Novel analytical and dissolution techniques for the characterisation of 
amorphous solid dispersions are included. Progress in understanding of amorphous 
supersaturation or recrystallisation from solution gathered from mechanistic studies is 
discussed. Aspects of powder flow and compression are considered in a section on 
downstream processing. Overall, spray drying has a bright future due to its versatility, 
efficiency and the driving force of poorly soluble drugs. 
Keywords: Spray drying; Solid dispersion; Amorphous; Poorly soluble drugs; 
Formulation 
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INTRODUCTION 
Spray drying is an excellent technique for the rapid removal of solvent from a system, 
yielding particles with various properties that can be specifically designed. In this review, 
there is a focus on the ability to produce drug-containing particles with an enhanced 
bioavailability. Due to the large number of poorly water-soluble drugs present in today’s 
market (and the even larger proportion currently under development), methods for generating 
drug particles with enhanced solubility are of crucial importance. 
Poorly water-soluble drugs: 
Poorly water-soluble drugs are now accounting for 40% of existing drugs and 70% of new 
chemical entities(Brouwers et al., 2009; Nagabandi et al., 2014; Williams et al., 2013). The 
solubility performance of drugs remains one of the most challenging aspects in formulation 
development today(Leuner and Dressman, 2000). The BCS classification system was 
introduced in 1995 as a systematic way of classifying drugs according to solubility and 
permeability properties(Amidon et al., 1995). Class II drugs are highly permeable and poorly 
soluble, but class IV drugs have low permeability and low solubility (Figure 1). 
 
Figure 1. Trend in the spray drying of drugs and poorly soluble drugs since 1998 , source Scopus
®
 
A variety of techniques for producing drug formulations with enhanced solubility are 
available(Savjani et al., 2012). Physical modifications include particle size reduction like 
micronisation or nano-sizing(Mosharraf and Nyström, 1995); modifications of the crystal 
habit include preparation of the amorphous form(Yoshioka et al., 1994) or preparing an 
alternative polymorph or co-crystal(Blagden et al., 2007). Drug dispersions can include 
eutectic mixtures(Law et al., 2003), solid dispersions(Leuner and Dressman, 2000), solid 
solutions and cryogenic techniques. Chemical modifications include changes in pH, using a 
buffer, derivatisation, complexation and salt formation(Serajuddin, 2007). Other methods 
involve the use of surfactants, solubilisers, the supercritical fluid processes, cosolvency, 
hydrotrophy and new excipients(Fahr and Liu, 2007). Several preparation methods designed 
to produce formulations with enhanced solubility relative to the untreated drug are of interest, 
particularly hot melt extrusion(Crowley et al., 2007), electrospinning(Kenawy et al., 2009), 
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rotary evaporation(Van Eerdenbrugh and Taylor, 2010), milling(Chieng et al., 2009), freeze 
drying(Dontireddy and Crean, 2011) and others, but here the primary focus will be on spray 
drying and the substantial level of research work taking place in this area. 
Spray drying 
Spray drying can be used to make amorphous solid dispersions, solid dispersions, 
microparticles, nanoparticles, self-emulsifying delivery systems, eutectic mixtures and other 
powdered products. The process has been described in many excellent articles and reviews 
and will not be described here in great detail(Cal and Sollohub, 2010; Paudel et al., 2013; 
Singh and Van den Mooter, 2016; Sollohub and Cal, 2010; Vehring, 2008). Essentially, a 
liquid solution (or suspension) is converted to a powdered solid. Liquid feed is usually 
pumped into a drying chamber via a nozzle where fine droplets rapidly encounter a hot 
drying gas. The wet gas and dry particles are then separated by a cyclone and / or bag filter 
and the powdered product is dispensed into a collection vessel and / or bag filter (Figure 2). 
Many different permutations of the spray drying apparatus exist, such as nozzle variations 
(two-fluid, pressure, rotary, vibrating), drying chamber geometry differences (height, width, 
material), direction of flow (counter-current and co-current), cyclone design, drying gas type 
and of course, scale. Critical process parameters include inlet temperature, outlet temperature, 
drying gas velocity, liquid feeding rate, feed concentration, feed viscosity and several 
others(Vehring, 2008). 
PRE-SCREENING OF FORMULATIONS 
The purpose of formulation pre-screening is to minimise the risk and cost associated with 
development. Pre-screening is particularly important during pharmaceutics research because 
of the high cost and limited availability of new chemical entities. A variety of practical, 
mathematical, and in silico approaches exist, with differing pros and cons. 
Practical methods like solvent casting (Davis et al., 2015) have the advantage of representing 
a real system, encountering problems that might be missed in mathematical assumptions or 
computer models. Only small quantities of drug and solvent are required to rapidly produce a 
variety of permutations whilst keeping costs and solvent levels relatively low. A design of 
experiment approach can also reduce the overall number of runs required for a specific 
formulation(Iannuccelli et al., 1998). Nevertheless, the Holy Grail continues to be 
computational or mathematical models to represent real systems as these can be performed 
much faster and with fewer requirements for resources. Examples of progress in these areas 
are mentioned later on. 
Not all practical pre-formulation techniques will adequately represent a commercial 
production outcome, so a variety of techniques are required. Atomic force microscopy and 
confocal Raman microscopy were used as tools to compare particles generated from a drying 
kinetics analyser with particles from a conventional spray drier(Whiteside et al., 2013). 
Griseofulvin was taken as a model drug at loadings of 2.5% and 20% with PEG 6000. With 
this model system, particles were found to be physically and chemically equivalent, 
indicating that single levitated droplet drying offers a viable pre-formulation technique for 
screening drug-polymer combinations. 
Improvement of mathematical equations to predict formulation behaviour is 
ongoing(Chatterjee et al., 2001; Tian et al., 2014). The Arrhenius equation can be used to 
measure the rate of degradation reactions from amorphous dispersions and predict stability. 
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Patterson et al. monitored the stability of dispersions of HPMC-AS for 6 months using 
HPLC(Patterson et al., 2015). Although the data reflected the impact of temperature and RH 
levels, it was clear that these terms alone did not account for all of the variability in the data. 
An extension to the Arrhenius equation to include a term for polymer chemistry improved the 
fit of the model. 
 
Figure 2. Schematic of a spray drying process in closed mode. The liquid feed is pumped 
through the nozzle and rapidly dries in the drying chamber before passing through the 
cyclone and filter to separate the particles from wet gas. A condenser traps the solvent and 
inert gas nitrogen is recycled back to the top of the drying tower in a closed loop using a fan. 
This configuration is often employed for spray drying lipophilic drugs. 
A novel computerised screening methodology designed for the early development of spray 
dried amorphous dispersions has been described(Duarte et al., 2015). The model combines 
thermodynamic, kinetic and manufacturing information in a series of partial differential 
equations to describe the evolution of drug-polymer microstructure. Itraconazole dispersions 
were prepared with a variety of polymers and a comparison was made to results obtained 
from the model. The results from the model were ranked according to miscibility and this 
compared well with the experimental data. If such in silico techniques can be developed to 
reliably predict the optimal formulation characteristics (e.g. loading) of a drug, they can be of 
enormous benefit. 
FORMULATION 
Choosing an appropriate excipient for the spray dried dispersion 
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Often polymeric excipients are chosen for spray dried dispersions of drugs and HPMC-AS is 
very popular(Curatolo et al., 2009). Considered a reliable excipient, it has been combined 
with many drugs and studied in many publications, e.g. Friesen tested 139 drug compounds 
in combination with this polymer(Friesen et al., 2008). Although HPMC-AS often performs 
well in spray drying and processing, it should not be regarded as the automatic choice for 
amorphous dispersions. The diversity of chemical structures in API requires a similar 
diversity in excipients. Hydrogen bonding may be essential for drug-polymer amorphous 
stability. If this is the case, then the polymer and API functional groups should be ‘tuned’ to 
maximise beneficial intermolecular attractive forces. Choosing the best excipient (or 
excipient blend) for a given API depends on a series of characteristics and publications 
reflecting this need are manifold(Patel et al., 2015b). There follows a series of examples of 
recent publications involving poorly water-soluble API that reflects this need for polymer 
variety: 
Anti-HIV drug efavirenz was formulated into spray dried dispersions with varying quantities 
of Soluplus® and characterised with multiple spectroscopic techniques(Lavra et al., 2017). 
Stability studies conducted at accelerated conditions (40 oC/75% RH) confirmed amorphous 
drug by PXRD and DSC after 12 months. Solubility and dissolution rates were both enhanced 
in the SDD as a function of polymer concentration. 
Dissolution enhancement of celecoxib by spray drying with excipients PVP and Isomalt from 
hydroalcoholic solution was reported to generate SDD with 20-fold to 30-fold enhanced 
dissolution(Ghanavati et al., 2017). FTIR studies provided evidence of hydrogen bonding 
between drug and PVP. Formulations had recrystallized after 1 month of storage at 75% RH, 
however. 
Solid dispersions of nifedipine (20-50%) and PVP were prepared by spray drying and 
analysed by FTIR, PXRD, DSC, SEM and in vitro dissolution(Ikasari et al., 2015). SDD were 
found to be granulated, yellow and free flowing and SEM showed the particles to be spherical 
and porous. FTIR spectra revealed no interaction between polymer and drug and all 
formulations were PXRD amorphous. Thermograms showed broad melting peaks for drug at 
lower temperature than pure drug, indicating some miscibility of the drug in the carrier. It 
was concluded that dissolution was related to drug load and that higher polymer levels 
increased drug dissolution. 
Both the solubility and the photosensitivity of amlodipine were improved by spray drying 
into dispersions comprising dextrin (1:10 w/w) and SLS (0.9% w/w)(Jang et al., 2013). 
Particles were smooth and spherical with average size of 12.9 µm. Drug was amorphous and 
storage stability was maintained for 6 months at RT. Dissolution of ASD was much faster 
than crystalline drug and plasma concentrations in rats were significantly higher, providing a 
2.8-fold increase (with SLS) and 2.0 fold increase (without SLS) in AUC value. 
Ferulic acid was spray dried at 10% or 20% in binary combination with one of PVP-K30, 
PEG 6000 or poloxamer-188(Nadal et al., 2016). The relative solubility was improved by 
increasing the carrier concentration and the formulations were found to be amorphous by 
PXRD and DSC. FTIR revealed the likelihood of hydrogen bonding in the PVP SDD only. A 
free-radical scavenging assay confirmed intact antioxidant activity and a statistically relevant 
increase in anti-platlet effect relative to pure drug. 
Structural and thermal properties of microparticles containing methotrexate and PLGA 
prepared by spray drying were analysed by a series of spectroscopic techniques(De Oliveira 
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et al., 2013). High levels of encapsulation efficiency (90%) and spherical particle 
morphology were obtained. 
The influence of a variety of excipients, solvent and packaging was studied with the objective 
of optimising the conditions for spray dried dispersions of fenofibrate (Hugo et al., 2013). 
The effect of polymer structure on SDD performance 
The influence of the polymer chosen when designing ASD can have a profound influence on 
the stability and performance of the dispersions. It is well understood that intermolecular 
attractions such as hydrogen bonding play a key role in the success of certain combinations. 
More detailed information is required for a deeper understanding and whilst optimisation of 
formulations by screening various polymers and drug loadings is common, some research 
groups have probed more deeply, by studying the impact of varying polymer functional group 
chemistry on SDD performance. Several examples follow: 
Ting and co-workers have reported the design and synthesis of a multicomponent polymer 
platform based on HPMC-AS (Ting et al., 2014). The controlled synthesis of the polymer 
involved varying the levels of hydroxypropyl, methoxy, acetyl, succinoyl and glucose groups 
to influence the amphiphilic balance, ionisation point, hydrogen bonding and glass transition 
temperatures of the resultant polymer analogues. Probucol was then selected as a model BCS 
class II drug and spray drying was used to form SDD with the various polymer analogues. 
Dissolution experiments revealed dramatic differences in bioavailability as a function of 
polymer chemistry. This highlighted the critical importance of chemically driven interactions 
in facilitating amorphous stability and supersaturation. It was found that increasing 
carboxylic acid moieties and replacing glucose acetates with hydroxyl groups helped to 
establish stabilising ionic character and polar connections. This work demonstrated the 
possibility of a structure-function relationship between drug and polymer in oral delivery.  
In a related publication, the deconstruction of HPMC-AS was undertaken in a study of how 
polymers mechanistically provide storage and supersaturation stability(Ting et al., 2015). A 
versatile polymeric platform analogous to HPMC-AS was constructed and spray dried with 
BCS class II drugs probucol, danazol and phenytoin. The polydisperse nature of the polymer 
was dismantled into well-defined polymeric zones and the performance of the drug-polymer 
SDD was tested by wide-angle XRD and in vitro dissolution tests. Certain functional group 
zones of the polymer were found to be crucial in drug performance, e.g. polymer containing 
acetyl and succinoyl groups only in SDD with probucol increased area under curve by 180-, 
112-, and 26-fold over pure drug at 10, 25, and 50 % loading (w/w) respectively. Danazol and 
phenytoin were best protected from in vitro recrystallisation using hydroxyl-rich water 
soluble polymer analogues. These findings provided fundamental insights into how excipient 
microstructure can affect ASD performance. 
Esters of HPMC including five synthetic esters and commercially available HPMC-AS were 
combined with phenytoin by spray drying(Yin and Hillmyer, 2014). The purpose of the work 
was to vary the ester groups in the polymer and verify the corresponding impact on drug 
stability in the formulations. The SDD at 10% drug load had little difference in bulk 
properties and only minimal amounts of crystalline drug were detected using SEM, PXRD 
and DSC. In solution, while the HPMC-AS SDD was initially effective at reaching high 
levels of supersaturation at the beginning, it was not capable of maintaining these levels due 
to rapid crystallisation of the drug. Contrastingly, SDD with several of the synthesised 
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HPMC esters achieved high initial supersaturation levels and maintained them over 90 
minutes or longer. 
Eudragit® RL was tested as a carrier for dispersions of the weakly acidic APIs indomethacin 
and naproxen, either alone or including PVP K25 (Dereymaker et al., 2017). In vitro 
dissolution performance and phase behaviour of the SDD revealed that inclusion of Eudragit® 
RL led to prolonged supersaturation and was suitable for higher drug loadings. Unexpectedly, 
nanocrystals of naproxen and indomethacin were formed in the presence of Eudragit® RL and 
this was regarded as a consequence of a dissolution-sorption-desorption processes driven by 
the charged polymer. 
A biodegradable polymeric matrix was used in the preparation of ASD microspheres of 
acetaminophen and ibuprofen by spray drying(Enriquez et al., 2014). The polymeric matrix 
was formulated using bovine serum albumin (BSA) and glutaraldehyde as crosslinker. 
Microspheres were about 2 µm and exhibited a zeta potential of -30 mV, indicating stability. 
Dissolution studies showed a constant release for 16 hours. Spray dried gelatin microspheres 
containing ganciclovir were also prepared by spray drying after cross linking with 
glutaraldehyde(Tran et al., 2014). Loading efficiency was 68% and in vitro release suggested 
that drug release was related to the extent of swelling, which was related to drug-to-polymer 
ratio. 
Li et al discussed the importance of selecting excipients based on the principles of polymer 
science(Li et al., 2017). 
Formulation optimisation 
Different aspects of the spray drying and / or formulation processes can be optimised. If a 
critical quality attribute (CQA) of the formulation requires optimisation, this can be done 
through design of experiments (DoE) and response surface methodology (RSM)(Patil et al., 
2014; Yousefi et al., 2015). Inlet variables such as temperature or feed concentration are 
related to critical quality attributes such as particle size distribution, dissolution or 
stability(O’Hara and Hickey, 2000). Other important outlet variables include yield, flow and 
moisture levels(Billon et al., 2000). Artificial neural networks (ANN) have also been used to  
predict particle quality parameters and in the study this compared favourably to RSM 
(Youssefi et al., 2009). 
If the purpose is to optimise a performance aspect of the formulation, such as stability, 
release, etc., then an optimisation approach based formulation (e.g. drug loading, polymer 
selection, second polymer etc.) is usually encountered. For instance, during a study to 
enhance the solubility of repaglinide particles by spray drying with a variety of polymers 
(Eudragit E100, hydroxyl propyl cellulose and PVP K30), formulations were optimised 
according to drug solubility, release profile, particle size and angle of repose(Varshosaz et al., 
2016). In vivo studies in diabetic rats demonstrated that the Eugragit E100 SDD in a  1:3 ratio 
enhanced drug solubility 100-fold. Furthermore, the SDD was PXRD amorphous and reduced 
blood glucose levels significantly, relative to untreated drug (p < 0.05). 
Ternary spray dried dispersions 
A successful ASD must have significantly enhanced dissolution relative to the crystalline 
drug, be resistant to rescrystallisation over 3 to 5 years of storage and maintain 
supersaturation during dissolution in vivo. Manufacturing criteria such as flow and 
compressibility further limit the number of ASD that can be commercially successful. 
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Meeting all of these requirements with one single excipient becomes increasingly unlikely 
and this has resulted in an upsurge of research into ternary systems in recent years. 
In a design of experiments approach, BCS class II drug itraconazole was combined with 
processing polymer Soluplus® and stability polymer HPMCP, generating a range of ternary 
spray dried dispersions(Davis et al., 2017). Stability was excellent (formulations were PXRD 
and DSC amorphous for 1 year at 40 oC/75% RH) and further characterisation by solid state 
NMR and small angle X-ray scattering indicated that the powders were amorphous. 
Dissolution studies indicated a 50-fold increase in itraconazole concentration levels relative 
to the crystalline drug in the best case. Furthermore, the inclusion of Soluplus® allowed for 
comparison with a similar DoE study, prepared through hot melt extrusion(Albadarin et al., 
2017). In this way a comparison between the spray dried and melt extruded formulations was 
made (in a statistically significant way) providing insights into stability, dissolution, thermal 
and spectroscopic differences between the two preparation techniques. 
The synergy between polymers hypromellose and methacrylic acid copolymer in spray dried 
dispersions was recently investigated(Ohyagi et al., 2017). Dissolution rates of the binary 
SDD were improved relative to the single polymer dispersions. Intermolecular association 
was analysed with DSC and solid state NMR and it was suggested that hydrogen bonding 
reformation was likely improving dissolution rates. Furthermore it was shown that a ternary 
dispersion with griseofulvin showed significantly higher supersaturation than the equivalent 
binary SDDs. 
The dissolution and precipitation behaviour of ezetimibe from ternary SDD in biorelevant 
media was described(Alhayali et al., 2017). Ternary dispersions were made by spray drying 
or melt quenching the drug in combination with PVP-K30 and poloxamer 188 and all were 
amorphous in nature. Crucially, dissolution at 25 oC lead to supersaturation, but at 37 oC 
rapid precipitation occurred, showing that results at lower temperatures cannot always be 
used to predict supersaturation at physiologically relevant temperatures. 
Ternary solid dispersions of curcumin (40%) were prepared by spray drying in combination 
with Gelucire®50 and 13-Aerosil®(Teixeira et al., 2016). The solubility in HCl and phosphate 
buffer improved up to 3600- and 7.3-fold, respectively. Accelerated stability tests showed the 
SDD to be stable for 9 months and in vivo pharmacokinetic studies showed a 5.5-fold 
increase in drug in rat blood plasma relative to standard drug. The dispersion was deemed a 
promising way to enhance curcumin bioavailability, particularly considering the ability to 
scale up. 
Atorvastatin calcium trihydrate (ATC) was converted into novel ternary SDD with HPMC E5 
and nicotinamide by rotatable central composite design(Paidi et al., 2015). An optimised 
formulation was selected following physiochemical, dissolution, stability and 
pharmacokinetic studies. The optimised ASD was amorphous with spherical morphology and 
exhibited a 4-fold increase in dissolution rate relative to crystalline ATC and significant oral 
bioavailability enhancement (134.11%). The stability of the amorphous form even under the 
stress of high temperature and humidity was attributed to hydrogen bonding between drug, 
HPMC E5 and nicotinamide. It was concluded that this formulation was a useful tool to 
enhance the bioavailability of ATC. 
The effect of spray drying parameters on the phase behaviour and efficacy of ternary SDD of 
API in poly (lactic-co-glycolic acid) (PLGA) and PVP was recently reported(Meeus et al., 
2015a). Differences were observed in miscibility of components, phase heterogeneity, 
particle size and morphology. The drug release of the formulations studied was not 
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influenced by these changes, however. It was considered likely that release was dominated by 
diffusion from the PVP layer through pores in the PLGA layer. 
Gelatin and ethylcellulose microparticles were made by spray drying in a study designed to 
develop and characterise fluoride delivery systems(De Francisco et al., 2013). Fluoride 
sources sodium fluoride, sodium monofluorophosphate or aminofluoride were combined with 
polymers ethylcellulose and surfactant polysorbate 80 or natural polymer gelatin and 
excipient mannitol and converted to powders by spray drying. Microparticles were found to 
be <145 µm for ethylcellulose dispersions and <124 µm for gelatin dispersions. Release 
profile of fluoride from the microparticles was found to be a modified, fitted first order 
Fickian diffusion. It was concluded that microparticles from spray drying could be used as a 
platform technology for oral delivery of fluoride. 
The release behaviour of cilastazol based on its preparation method and the ratio of 
HPMC/PVP was studied(G. B. Park et al., 2013). Spray dried dispersions were produced with 
drug, HPMC and PVP at varying levels in ternary dispersions and dissolution studies were 
conducted at gastric pH. 
Novel ternary SDD of rebamipide with poloxamer 407 and PVP-VA-64 were made by spray 
drying to improve the bioavailability of the drug(C.-W. Park et al., 2013). Pharmacokinetic 
and pharmacodynamic testing in rats indicated that the drug bioavailability was 2-fold higher 
than a reference product and that irritation of the stomach was significantly reduced. 
An improvement in the intestinal absorption of probucol by preparation of an SDD with 
Eudragit was reported(Nishino et al., 2012). Drug was combined with polymer in organic 
solvent and an aqueous solution of mannitol was prepared separately. Both solutions were 
concurrently fed to separate feed ports on the nozzle and dried simultaneously. Drug in the 
matrix was amorphous and the bioavailability in rats was found to be significantly enhanced 
with respect to the untreated drug. 
Tenoxicam dispersions with two molar equivalents of L-arginine and 10-50% (w/w) PVP 
were prepared by spray drying(Patel et al., 2012). SDD provided a 2-fold increase over 
equilibrium solubility at the same pH. Solid state NMR studies revealed molecular 
associations and the formation of a glass solution between the drug and two excipients. 
Miscibility of components 
Miscibility is important because an amorphous solid dispersion that is intimately mixed is 
more likely to resist recrystallisation during the stresses of processing, storage and 
dissolution. Not all drug-polymer combinations or preparation techniques result in a single 
homogenous layer and a deeper understanding of the factors affecting miscibility is 
required(Marsac et al., 2009; Qian et al., 2010). Favourable mixing will occur when 
interactions such as hydrogen bonding and dipole-dipole interactions between drug and 
polymer outweigh interactions between individual components. Miscibility is further affected 
by drug loading, heat, humidity, particle morphology, particle size distribution and 
preparation technique. 
The effects of drug and polymer miscibility on the dissolution rates of both drug and polymer 
were recently reported(Higashi et al., 2015). Dispersions of phenytoin and glibenclamide 
were prepared with Eudragit® S 100 polymer. Dissolution tests of phenytoin dispersions were 
highly dependent on the drug loading, but glibenclamide results were independent of drug 
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loading. Drug-rich and polymer-rich domains were evident in both cases, but with phenytoin 
these areas were more easily converted into the crystalline form on contact with liquid. 
Phase separation in amorphous solid dispersions was characterised by applying isothermal 
calorimetry at 37 oC / 100% RH to SDD of BMS-903452 and BMS-986034(McNamara et al., 
2017). Although both drugs were individually combined with HPMC-AS at various loadings, 
BMS-903452 formed a physically robust formulation at 30% that was stable for 6 months, 
but the chemically analogous BMS-986034 could not be formulated at any load attempted. 
Isothermal calorimetry as a screening tool (over three days) proved to be very useful in 
predicting separation, particularly when used along-side orthogonal methods such as PXRD, 
solid state NMR and FTIR. 
An extensive solid-state miscibility study was conducted using model drug ABT-102 and 9 
different polymers, followed by analysis using DSC, FTIR and PXRD(Jog et al., 2016). 
Serial dilution, solvent evaporation and spray drying were used as preparation techniques, 
with spray drying proving most useful. Melting point depression was used to calculate the 
interaction parameters and free energy of mixing of the drug-polymer systems. Soluplus® was 
found to be the best stabiliser, possibly due to hydrogen bonding between C=O in Soluplus 
and N-H in the drug. 
Phase separation processes were recently studied in dispersions of AMG 517 with HPMC-AS 
using DSC and solid state NMR(Calahan et al., 2015). A weakly asymmetric (ΔTg ≈ 13.5) 
system with a single glass transition for different blends suggested mixing. Proton spin-lattice 
relaxation times also suggested that the components were in intimate contact over a 10-20 nm 
scale. Upon calculating the Flory-Huggins free energy of mixing, however, the 
thermodynamic values were positive, signifying that drug and polymer will inherently 
separate over time. These results suggested that the homogeneity observed by DSC and NMR 
were achieved kinetically and that this accounted for the stability of the ASD. 
The miscibility of drug-polymer SDD across a spray dryer was studied using model drugs 
naproxen and miconazole(Worku et al., 2014). In this work a wide variety of drug-polymer 
compositions were prepared on assorted laboratory scale spray driers and recovered from 
various locations. SDD with 30% (w/w) naproxen collected from the transport tube of the 
Pro-C-epT Microspray dryer showed the finest glass transition width, which seemingly 
indicates the highest level of drug polymer mixing. Samples with 50% (w/w) naproxen 
collected from the cyclone of the Büchi mini spray dryer showed a melt endotherm with heat 
of fusion between 0.7 and 1.8 J/g. The study demonstrated that a disparity in drug polymer 
miscibility can occur in miscellaneous regions of the spray dryer during small-scale 
preparation and a mindfulness of such is crucial when scaling up. 
Silica as a carrier 
Silica offers an inorganic alternative to organic excipient polymers due to its high surface 
area, porous structure, heat stability and chemical interactions via silanol (Si-OH) groups on 
the surface(Shen et al., 2011; Takeuchi et al., 2005; Watanabe et al., 2003). 
The solubility of anti-malaria drug artemisinin was improved by encapsulation with ordered 
mesoporous silica SBA-15 (Letchmanan et al., 2015). Formulations showed significantly 
enhanced dissolution rates and supersaturation with respect to the untreated drug. 
Cytotoxicity studies of the SDD using Caco-2 cells demonstrated promising biocompatibility. 
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SDD were further tested for storage stability over 6 months and exhibited excellent physical, 
but poor chemical stability due to a sensitivity of the API towards humidity. 
Nano-domains of drug were found in spray dried ibuprofen-silica microspheres with the drug 
domains found to be 40 nm in diameter from NMR and TEM studies(Fatnassi et al., 2012). 
Microparticles of hydrochlorothiazide were prepared by spray drying with PVP and colloidal 
silicon dioxide using a three-level Box-Behnken design(Martins et al., 2012). Process yields, 
moisture levels, PSD, flow and solubility of the microparticles were analysed using response 
surface methodology with analysis of variance. Solubility and dissolution rates were 
significantly improved relative to pure drug. 
Ibuprofen was spray dried with a variety of mesoporous silica materials of different pore and 
particle sizes (Shen et al., 2011). It was found that the silica pore size affected the physical 
state and the particle size of the drug. If the pore size was less than 10 nm, amorphous drug 
was obtained, but if the carrier pore size was greater than 20 nm, nanocrystals were formed. 
Moreover, drug dissolution was most affected by the physical state of the drug, followed by 
diffusion kinetics, PSD and finally path length. 
Fixed dose combinations prepared by spray drying 
Two or more drugs contained in a single dosage form have the advantage of reducing the 
number of pills a patient need take each day and this can improve both adherence and 
treatment outcomes. There can also be pharmacokinetic advantages(Connolly et al., 2009; 
Scagliotti et al., 2008) or disadvantages relative to the single drug. Spray drying is becoming 
more prevalent as a preparation method. 
A fixed dose combination (FDC) of ezetimibe and lovastatin was recently converted into a 
co-amorphous system or a ternary dispersion by spray drying and quench cooling 
methods(Riekes et al., 2016). Although co-amorphous systems did not increase the 
dissolution rate of either drug, ternary SDD (containing Soluplus®) increased dissolution by 
18-fold for ezetimibe and 6-fold for lovastatin. This result was seen as promising for the 
development of more advanced fixed dose combinations. 
A fixed dose combination of ritonavir and darunavir in the form of dispersible powders was 
prepared by spray drying(Nguyen and Van Den Mooter, 2014). An excipient polymer (one of 
HPMC, PVP or PVPVA-64) was combined with either drug and the influence of the 
polymers on supersaturation levels was investigated. The concentration of both drugs was 
found to drop quickly then level out to a plateau and this was considered to equate to the 
amorphous solubility concentration. Also, the inclusion of darunavir diminished the 
supersaturation level of ritonavir and vice versa regardless of which polymer was engaged. 
Furthermore, the rate of drug release was less for both drugs from ternary SD than binary SD 
powders. NMR studies excluded the presence of intermolecular interactions between the two 
drugs, implying that the supersaturation level must at least be partially attributed to a solvent 
mediated process. 
Solubility enhancement through nanotechnology 
Nanotechnology is widely expected to have a substantial impact on drug delivery strategies 
and in particular nanoparticles will be pertinent (Parveen et al., 2012). Advantages of 
nanoparticles include an increase in drug solubility, protection from degradation, targeted 
delivery and a reduction in toxic side effects. As more and more new chemical entities face 
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issues with solubility, toxicity or dosage levels, a series of publications preparing 
nanoparticles through spray drying have appeared. 
Natural polymeric coating materials were engaged in the preparation of solid lipid 
nanoparticles (SLN) and of nanostructure lipid carriers (NLC) by nano spray drying (Wang et 
al., 2016). Uniform, well-separated, spherical powder particles were attained for NLC, 
although SLN were aggregated and had irregular shape. Formulation optimisation with 20–
30% oleic acid and carrageenan or pectin as coating materials achieved the best result. These 
results were deemed to represent proof of concept for lipid delivery systems via nano spray 
drying. 
In situ analytical techniques (such as NMR) were used to study drug supersaturation nano-
sized and amorphous states (Ueda et al., 2015). Ternary formulations of carbamazepine with 
HPMC and sodium dodecyl sulfate were prepared by spray drying and grinding. Drug was 
completely amorphous following spray drying, but some crystals remained in the ground 
mixture. Aqueous dispersions of SDD formed transparent solutions but dispersions of ground 
mixture formed nanoparticles of around 150 nm. Drug permeation studies showed drug 
concentration in the bulk water phase rapidly reduced from the spray dried dispersion 
compared to the ground mixture. The ground mixture may have an advantage of maintaining 
a supersaturated state due to the presence of nanoparticles. 
A DoE study was conducted to investigate the in vitro dissolution performance of spray dried 
nano-crystalline powders of naproxen(Kumar et al., 2015). Wet milling parameters, such as 
drug concentration, drug-excipient ratio, excipient type (HPMC E15 or Tween 80) and 
milling intensity were of critical importance. Trehalose and lactose were engaged as auxiliary 
excipients to lessen particle aggregation. The size of the nano crystals was dependent on drug 
concentration and milling intensity. A better spray drying yield was found with formulations 
comprising HPMC E15 relative to Tween 80. Trehalose was selected to reduce aggregation 
and no polymorphic changes were observed following wet milling or spray drying. 
Nanocomposite microparticles (NCMP) were prepared by wet milling and then spray drying 
griseofulvin and hydroxypropyl cellulose (HPC) in the presence of various dispersants(Azad 
et al., 2014). The purpose of the work was to compare the effect of various dispersants on 
drug dissolution, with the overall goal of enhancing the bioavailability of poorly soluble 
drugs through high drug loaded, surfactant-free NCMPs. The best dissolution enhancement 
was obtained with formulations of drug-HPC with croscarmellose sodium and sodium starch 
glycolate and this achieved a rapid release comparable to SDS. 
Burgess and co-workers used a DoE approach for the optimisation of spray drying with the 
purpose of forming crystalline nanosuspensions of BCS class II/IV compounds(Kumar et al., 
2014). It was established that glass transition temperature and charge effects had a strong 
effect on powder yield. Flory-Huggins interaction parameter agreed closely with spray dried 
nanocrystal formulation stability. 
The influence of spray drying parameters on nanocrystal porosity and dispersibility is heavily 
depend on drying method employed(Khoshkava and Kamal, 2014). In this study, a 
comparison of spray drying, freeze drying and spray-freeze drying concluded that spray-
freeze dried samples performed best. 
The dispersibility and bioactivity of curcumin was enhanced by encapsulation in casein 
nanocapsules through spray drying(Pan et al., 2013). After hydration and centrifugation, 137 
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µg/mL curcumin was dissolved in the supernatant which was 4 decades higher than the 
crystalline water solubility. 
Solid nanocrystalline dispersions of ziprasidone were prepared by exposing an amorphous 
spray dried dispersion to a controlled temperature and relative humidity(Thombre et al., 
2012). The goal of the work was to enhance oral absorption in the fasted state, thereby 
reducing the food effect. The formulation was administered orally to beagle dogs and 
pharmacokinetic studies showed complete fasted-state absorption of drug, attaining the 
intended enhancement in fed/fasted ratio. 
Wet nano-milling was used prior to spray drying to produce a dry nanosuspension of 
phenytoin(Niwa et al., 2011). SEM analysis revealed 1 µm agglomerates composed of 
thousands of nano drug crystals. These particles could be spontaneously redispersed in water, 
in contrast to the equivalent formulation prepared from solution rather than nanosuspensions. 
The oral bioavailability of 7 formulations of curcumin were compared using in vivo studies in 
rats(Munjal et al., 2011). Results with nanosuspensions, cyclodextrin complex and ASD were 
251%, 567% and 446% increase in AUC respectively.  
Preparation of self-emulsifying delivery systems via spray drying 
Self-emulsifying drug delivery systems (SEDDS) are mixtures of oils, surfactants, solvents 
and co-solvents used for improving the oral absorption of lipophilic drugs(Gursoy and 
Benita, 2004). They are generally administered as gelatin capsules and form oil-in-water 
(o/w) emulsions upon aqueous dilution during their passage through the gastrointestinal 
fluids. Hansen reported a spray dried emulsion containing a poorly water-soluble drug in 
2004(Hansen et al., 2004). In recent years there have been an increasing number of 
publications involving SEDDS prepared by spray drying(Balakrishnan et al., 2009; Goddeeris 
and Van den Mooter, 2008). 
A solid SEDDS was developed for erlotinib using excipients dextran 40 and Aerosil® 
200(Truong et al., 2016). Oil, surfactant and co-surfactant were blended and a ternary phase 
diagram was created to evaluate the self-emulsifying area. Optimised SEDDS formulations 
were spray dried and characterised as amorphous. Pharmacokinetic parameters such as Cmax 
were significantly improved (p < 0.05) relative to unprocessed drug, so it was concluded that 
SEDDS could be a promising delivery route for erlotinib. 
The oral bioavailability and physiochemical properties of clopidrogel napadisilate was 
explored using solid self-microemulsifying drug delivery system (SMEDDS) prepared by 
spray drying(Kim et al., 2014). Liquid SMEDDS comprising oil (peceol), a surfactant 
(Cremophor RH60) and a co-surfactant (Transcutol HP) was optimised using a ternary phase 
diagram, then spray dried onto silicon dioxide yielding solid SMEDDS. The physiochemical, 
solubility and pharmacokinetics of the formulations were assessed and compared to 
clopidogrel napadisilate and clopidrogel bisulfate powders. Although the drug was in the 
crystalline form in the SMEDDS, solubility was better than in untreated clopidrogel 
napadisilate. Accelerated stability was enhanced relative to powdered form. Nevertheless, it 
was also found that a solid dispersion of drug with surfactant and polymer significantly 
improved bioavailability relative to both SMEDDS and untreated drug powder. 
A novel re-dispersible dry emulsion of valsartan in HPMC was reported to be very effective, 
with enhanced, pH-independent drug release and significantly improved bioavailability(Baek 
et al., 2014). The system comprised of drug valsartan, polymer HPMC, oil Caprilol 90 and  
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Figure 3: A schematic representation of oral delivery carrier systems prepared via spray 
drying and their constituent parts; including (a) crystalline drug, (b) amorphous solid 
dispersion (one phase, solid solution), (c) polymer, (d) crystalline solid dispersion (two phase 
system), (e) amorphous solid dispersion (two phase system),(f) microparticles (spherical), (g) 
nanoparticles (spherical), (h) ternary amorphous solid dispersion containing surfactant, (i) 
ternary amorphous solid dispersion with two polymers, (j) self-emulsifying drug delivery 
system (SEDDS), (k) silica nanoparticles, (l) fixed-dose combination amorphous solid 
dispersion.  
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surfactant poloxamer 407. Mean droplet emulsion size ranged from 133 to 152 nm during 
dispersion in water. 
Stable dry emulsions of itraconazole were designed by full factorial spray drying DoE(Rao 
and Aghav, 2014) and a 71% increase in Cmax and 115% improvement in AUC were 
measured relative to untreated drug. 
An overview of popular delivery vehicles prepared by spray drying is given in Figure 3. 
Drug release from emulsions for effective dermal and transdermal delivery 
Dermal drug delivery involves topical application to the skin to treat local diseases, 
whereas transdermal drug delivery represents transport through the intact skin into systemic 
circulation for the treatment of various chronic disorders(Shakeel et al., 2012). In some cases, 
this route may offer several advantages, such as enhanced bioavailability, reduction in side 
effects and averting the first pass effect in the liver. 
To achieve dermal delivery of drugs by passive transport, formulation optimisation is 
required. Firstly, the oil/water partition coefficient must be very low, secondly the molar 
mass of the drug must be >500 gmol-1, thirdly the percutaneous absorption should be very 
low, fourthly the permeation rate through the skin should be low and finally the systemic 
bioavailability should be low. For transdermal delivery the opposite applies, although active 
transport may be necessary for adequate delivery. Active transport methods such as 
iontophoresis, electroporation (electrical energy), abrasion, ablation, perforation (mechanical 
energy) or ultrasound have improved delivery across the stratum corneum(Brown et al., 
2006). 
The impact of surfactants on the physical stability of SDD 
The higher energy of amorphous forms leads to solubility levels orders of magnitude higher 
than the crystalline forms, but can also lead to spontaneous recrystallisation. Exposure to 
heat, moisture and solvent tends to increase recrystallisation rates. The dissolution medium is 
often a complex multicomponent environment and an understanding of the impact of each 
component on stability has been limited. Much focus has been directed on the influence of 
polymers on physical stability, but more recently the effect of surfactants on the performance 
of spray dried dispersions has been receiving more and more attention. 
The impact of surfactants on the crystallisation behaviour of spray dried particles was 
recently reported by Taylor and co-workers(Chen et al., 2015). Solid dispersions of celecoxib 
with HPMC-AS were added to acidic media containing various surfactants. Nucleation 
induction times in the presence and absence of surfactant were measured. Sodium dodecyl 
sulfate and Polysorbate 80 were found to promote crystallisation while sodium taurocholate 
and Triton X100 were found to inhibit crystallisation. Crystallisation was found to be related 
to the effect of the surfactant on nucleation and the tendency of the surfactant to leach the 
drug from the SDD into the surrounding media. Mindful surfactant selection is therefore 
critical in order to avoid ASD failure through drug recrystallisation. 
Griseofulvin was combined with PVP or PHPMA via spray drying or bead milling and the 
effect of ionic surfactant (sodium dodecyl sulfate) and non-ionic surfactant (Tween-80) on 
the physiochemical properties was studied(Al-Obaidi et al., 2016). The formulations were 
found to recrystallise quickly and DVS measurements indicated an increased water uptake. 
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Slower dissolution rates were observed for ASD containing surfactant. Dispersions prepared 
by milling showed better stability than SDD. 
The effect of plasticisers on the properties of microparticles made by spray drying was 
reported using theophylline as a model compound(Wan et al., 1992). Formation of pores due 
to the leaching of plasticisers from SDD particles into dissolution media enhanced drug 
release. Flow property analysis demonstrated that the plasticisers also affect the cohesiveness 
of the microparticles. 
The role of polymer-surfactant interactions in spray dried dispersions of Ertravirine with 
HPMC and bile salt or SDS has been studied(Qi et al., 2013). Dissolution experiments and a 
range of spectroscopic techniques revealed that the maximum increase in apparent solubility 
of the drug was when both HPMC and surfactant were present. 
Selecting an appropriate solvent and monitoring residual solvent levels 
Selection of a suitable solvent system is one of the key requirements when formulating an 
amorphous dispersion by spray drying. Usually the solvent must be capable of dissolving all 
of the components of the dispersion(Paudel et al., 2013). The viscosity of the feed solution 
must be appropriate and solvents of low toxicity and high volatility are preferred. ICH 
guidelines for residual solvents recommend the use of less toxic solvents and set limits for 
residual organic solvent levels in drug substances(ICHQ(R6)). Several groups have 
researched methods for detecting trace levels of solvent in spray dried particles or explored 
replacement solvents with better toxicity profiles. 
A strategy to mitigate the risk of ICH Class 1 impurity benzene reaching drug product in 
spray dried dispersions was reported(Yue et al., 2015). The risk assessment considered the 
likelihood of residual benzene from primary spray solvents being concentrated in the product. 
A spiked fate and tolerance study simulating worst case scenario conditions was performed, 
demonstrating that the mass ratio of spray solution to solid was a critical risk parameter. Slow 
spray drying kinetics reduced benzene levels by about 700-fold. A secondary drying step was 
also recommended. Two critical control points were identified: (i) maximum residual 
benzene levels of 10 ppm and (ii) in-process control of residual solvents in SDD. 
Gas chromatography was used to monitor residual acetone levels in spray dried intermediates 
(Quirk et al., 2014). Due to high levels of polymer, direct liquid injection with gas 
chromatography (GC) was not a feasible option, so headspace autosampling (GCHS) was 
utilised instead. Method development involved a number of analytical challenges including 
application of a conversion factor to correct for reactions occurring between acetone and 
related impurities (mesityl oxide and diacetone alcohol). After additional optimisation the 
approach was deemed robust and capable of determining acetone and the impurities over the 
concentration range 0.008-0.40 µL/mL, with limit of detection of 20 ppm. 
SDD of poorly water-soluble drug raloxifene were prepared without using an organic 
solvent(Tran et al., 2013). Drug, PVP and surfactant Tween 20 were added to water and spray 
dried yielding particles with a mean size of 180 nm. Formulations showed an enhanced 
dissolution rate relative to untreated drug at pH 1.2, 4.0, 6.8 and in distilled water. During in 
vivo bioavailability tests in rats, the pharmacokinetic parameters of SDD showed increased 
AUC and Cmax of 3.3-fold and 2.3-fold respectively. 
The influence of solvent on the miscibility and physical stability of SDD of naproxen with 
PVP was studied(Paudel and Van Den Mooter, 2012). Dispersions were prepared by spray 
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drying solutions of drug and polymer using binary blends of methanol, dichloromethane and 
acetone at varying levels. It was found that SDD prepared from solvent/anti-solvent mixtures 
showed better miscibility and better physical stability than those from blends of ‘good’ 
solvents. Furthermore FTIR spectra indicated differences in drug-polymer interactions in 
solid dispersions from different solvent blends. 
 
Figure 4. Trend in spray drying publications with specific delivery strategies for years 2010 and 2016 , 
source Scopus
®
 
Recent trends since 2010 have shown an increase in publications in amorphous systems, 
microparticles, nanoparticles and solid dispersions (Figure 4). 
PROCESS OPTIMISATION 
A number of mathematical, statistical and in silico techniques are utilised in process 
optimisation, such as design of experiments (DoE), response surface methodology (RSM), 
analysis of variance (ANOVA) and artificial neural networks (ANN). The trend has been to 
move away from a trial-and-error (Edisonian) approach(Amis et al., 2002). 
A Plackett-Burman design was recently applied to the design of operating and formulation 
parameters when preparing diclofenac-polymer microspheres by spray drying(Deshmukh and 
Naik, 2016). Eudragit® RS100 quantity, ethylcellulose quantity and aspirator rate were found 
to be significant factors. Encapsulation efficiency ranged from 47.55 to 67.99% and the 
microspheres were discrete, spherical and smooth. In vitro drug release was sustained over 12 
hours and followed a Korsmeyer–Peppas model with slope (n) ≤ 0.43 indicating a Fickian 
diffusion. 
A DoE approach was taken to optimise the spray drying process on a Büchi B-90 using a 
central composite design(Gu et al., 2015). Polymer concentration, inlet temperature and air 
flow rate were taken as input variables with yield, spray rate and drying efficiency as outputs. 
The model was further tested using a poorly soluble drug, generating a range of formulations 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
of 2-10 µm that were found to be physically stable (for 3 h) in aqueous methyl cellulose 
solution (1%). 
The solubility of nifedipine was enhanced by spray drying with poly(meth)acrylates 
following a pre-screening solvent casting method (Patel et al., 2015a). The effect of spray 
drying process parameters was examined in a 23, full factorial, DoE approach. Dissolution 
studies revealed a significant enhancement of 90% drug release in 20 min relative to 12% 
from crystalline drug. SEM images indicated uniform, spherical particles and DSC and 
PXRD showed samples to be amorphous after 3 months storage. Feed rate had a significant 
effect on in vitro dissolution, whereas solid content had the highest effect on process yield. 
An optimisation of the process variables of spray drying using different statistical techniques 
was made by Patel(Patel et al., 2014). Response surface model and ensemble artificial neural 
network methods were employed. Pearson correlation analysis, self-organising maps, contour 
plots and response surface plots were used to illustrate the effect of input variables on quality 
attributes. 
The Büchi B-90 spray drying process was optimised using a central composite design 
focusing on the effects of polymer concentration, inlet temperature and air flow rate on yield, 
spray rate and drying efficiency(Gu et al., 2015). 
A study was conducted to ascertain the critical processing parameters of a laboratory-scale 
spray drier affecting solubility behaviour and physical stability of solid dispersions(Kojima et 
al., 2013). Nitrogen flow rate, sample concentration and pump speed were varied and the 
powders were characterised by spectroscopic techniques, dissolution tests and physical 
stability testing. It was found that low nitrogen flow rate and high sample concentration gave 
the most favourable solubility behaviour and physical stability results. 
A model for predicting the quality attributes of binary solid dispersions of drug-polymer from 
spray drying using response surface model and ensemble artificial neural network was 
reported(Patel et al., 2013). 
The effects of changing spray drying temperature and atomising airflow rate were studied by 
Paudel et al(A Paudel et al., 2013). Taking a naproxen-PVP system, they monitored the phase 
structure, physical stability and performance of the resultant ASD. Higher inlet temperatures 
produced phase-separated dispersions whilst lower inlet temperatures produced more 
homogenous dispersions. Higher inlet temperature ASD retained more amorphous drug 
content during a three week stability trial at 75% RH. The rate and extent of drug dissolution 
from the highest atomised ASD was higher. 
Nozzle modifications 
Traditionally, the two-fluid nozzle has been the most popular choice for preparing amorphous 
spray dried dispersions of pharmaceuticals, but this is changing. Alternative nozzle types, 
such as the pressure nozzle(Beyerinck et al., 2010) or vibrational nozzle can produce larger 
particles with better flow properties. 
Sildenafil has been incorporated into poly(lactide-co-glycolide) microparticles by vibrational 
spray drying(Beck-Broichsitter et al., 2016). Microparticles were optimised to a size range of 
4-8 µm with a sildenafil encapsulation rate of >90%. A scaled-up preparation process did not 
cause significant changes to physiochemical properties or in vitro drug release. 
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A 4-fluid nozzle was used to prepare matrix particles of acetaminophen with chitosan (ratio 
1:5) to achieve sustained release(Chen et al., 2006). 
COMPARISONS WITH OTHER PREPARATION TECHNIQUES 
Comparisons between manufacturing techniques can reveal information on the impact of 
processing on the critical quality attributes of an ASD. Comparisons with hot melt extrusion, 
freeze drying, milling, electro spinning, electrospraying, precipitation, film casting, rotary 
evaporation and other techniques are frequently reported. Formulation and process 
optimisation using DoE and analysis of variance or RSM interpretation of results is an 
increasing trend in such publications. 
 
An improvement on the dissolution of albendazole by amorphous solid dispersions was 
studied comparing spray drying and hot melt extrusion (Hengsawas Surasarang et al., 2017). 
Flory-Huggins theory was used to construct phase diagrams of the binary dispersions of drug 
with polymer to assess miscibility and processability. Despite the precaution of forced 
chemical and thermal degradation studies, it was found that albendazole was not stable during 
hot melt extrusion, with degradation up to 97.4%. It was possible to make amorphous drug by 
spray drying, however. SDD containing drug with acids and polymers were prepared and 
found to have up to 8-fold improved non-sink dissolution in acidic media and good shelf life 
stability (intact up to 6 months or 5% degradation after 1 year). It was concluded that 
amorphous albendazole solid dispersions in combination with acid and polymer could be 
prepared by spray drying, but were degraded by hot melt extrusion. 
 
In a recent publication, the authors hypothesised that hot melt extrusion was a better 
manufacturing technique than spray drying when the API in question had a high 
crystallisation tendency(Haser et al., 2017). To examine this, systems of naproxen with 
povidone K25 at 30% and 60% drug loadings were prepared and analysed using PXRD, 
DSC, FTIR and solid state NMR. At 30% drug loading, hydrogen bonding sites of povidone 
were unsaturated and the glass transition area was higher, so both spray dried and melt 
extruded materials were amorphous and remained so at 40 oC. At 60% drug load, H-bond 
sites were saturated and the glass transition area was lower. It was not possible to prepare 
fully amorphous materials and the quantity of crystalline material increased to 2.7% ± 0.3% 
and 21.6% ± 1.0% for hot melt extruded and spray dried materials respectively. It was 
rationalised that the spray dried formulation was more susceptible to recrystallisation due to 
higher drug diffusivity in the dispersion, a lack of kinetic stabilisation from the polymer 
solution, a greater number of nucleation sites and a higher surface area relative to the melt 
extruded dispersion. It was concluded that there were unique advantages to formulating high 
drug levels of naproxen by hot melt extrusion, although no mention was made of dissolution 
studies. 
Indomethacin was spray dried in combination with PVP and the resultant ASD was compared 
to similar formulations made by co-milling and supercritical anti-solvent processes(Lim et 
al., 2017). Samples were characterised by SEM, TGA, PXRD, physical stability testing, FTIR 
and Raman spectroscopy. It was found that PXRD amorphous formulations could be 
prepared with up to 80% drug load by spray drying and up to 60% drug load by the other 
techniques. Furthermore the samples made by SD and supercritical antisolvent techniques 
were stable for 6 months at 40 oC/75% RH. 
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A spray drying method has recently been reported as an improvement on freeze drying for the 
production of ASD of docetaxel or paclitaxel for phase 1 clinical trials(Sawicki et al., 2016).  
Both saturation solubility (Smax) and precipitation onset time (Tprecip) were equal or better to 
the freeze-dried results for both drugs. Furthermore, the process was more suited to scaling 
up and SDD were fully amorphous with a mean batch yield of 84%. Flow properties were 
poor and this was not improved by changing settings, but by employing lactose at 75% as 
diluent. Drug product tablets were stable for 24 months and spray drying was deemed 
suitable for producing ASD for phase 1 clinical trials. 
In order to improve the oral absorption of flubendazole, three drug delivery technologies 
were evaluated: spray drying, modified spray drying (using a flash nozzle) and formulation 
with ordered mesoporous silica(Vialpando et al., 2016). The formulations were tested for 
physiochemical stability and in vitro release and only the modified spray dried and ordered 
mesoporous formulations did not crystallise following 2 weeks at 40 oC/75% RH. In vivo 
testing revealed that the highest area under the curve and Cmax values were achieved by the 
ordered mesoporous formulation. 
Celecoxib was combined with Phospholipoid E80 and trehalose to create solid phospholipid 
nanoparticles via spray drying or freeze drying(Fong et al., 2015). An optimal ratio of 
1:10:16 produced amorphous spherical particles by spray drying and amorphous matrix-like 
structures by freeze drying. Although both formulations increased the dissolution rates and 
apparent solubility of drug in phosphate buffer, the spray dried dispersions achieved the 
larger enhancement in apparent solubility (29- to 132-fold) and molecular solubility (18-fold) 
at equilibrium. 
Slow release caffeine was combined with polymers PLGA and PLA using spray drying or 
electrospinning technology(Sóti et al., 2015). Both dispersion types were characterised by 
SEM, PXRD, DSC, at-line Raman mapping and in vitro dissolution. The ultrafine fibres from 
electrospinning were easier to handle than the microspheres from spray drying and also had 
slightly better dissolution performance. 
High speed electrospinning (HSES) was compared with single needle electrospinning, spray 
drying and film casting as preparation methods for ASD that are compatible with the 
pharmaceutical industry(Nagy et al., 2015). Itraconazole with PVPVA64 was the model drug-
polymer system and this was shown to be amorphous by PXRD and DSC in all cases except 
for film casting. The dissolution rate of itraconazole was vastly improved compared to 
crystalline: >90% within 10 min for the electrospun fibres, although the improvement for 
spray dried microspheres was lower. 
Solid dispersions of BCS class IV drug tolvaptan were prepared by hot melt extrusion and 
spray drying with a variety of polymers such as Soluplus®, copovidone, PVP and 
hypromellose in order to improve aqueous solubility(Ramesh et al., 2015). Higher drug 
release levels were found in dispersions from HME relative to SDD. There was a 7-fold 
increase in solubility in dispersions from both methods compared to the crystalline drug. 
Physical characterisation of both formulations by FTIR, DSC, PXRD and SEM revealed a 
change in crystal structure towards an amorphous form. 
ASD of celecoxib with Soluplus® have been prepared by spray drying, solvent evaporation 
and melt methods at a range of drug loadings(Homayouni et al., 2015). Particles were 
characterised by particle sizing, optical microscopy, SEM, PXRD, DSC and FTIR. 
Experimental values of Tg were compared to those predicted by the Gordon-Taylor equation. 
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Solubility and dissolution rates were studied. Stability testing at ambient conditions for 12 
months revealed the formulations to be PXRD and DSC amorphous. The 1:2 spray dried 
ASD had the optimal dissolution rate although very high drug loadings (2:1 and 1:1) 
surprisingly had slower dissolution than crystalline drug. Stability studies showed no 
decrease in dissolution rate after 12 months ambient storage. Overall it was concluded that 
Soluplus® was a suitable carrier to enhance dissolution of celecoxib. 
A comparison was made between hot melt extrusion and felodipine as preparation techniques 
for creating ASD of felodipine(Mahmah et al., 2014). The purpose of the work was to 
compare the properties of the solid dispersions from the two techniques. Two different 
polymers PVP and HPMC-AS were chosen and used at several different ratios. 
Characterisation of ASD was performed using DSC, PXRD, SEM and in vitro dissolution. 
Stability of ASD was studied over accelerated conditions of 40 oC/75% RH over 8 weeks. 
Key findings were that spray dried formulae released felodipine faster than melt extruded 
felodipine for both polymer matrices. SD with HPMC-AS had higher drug release rates and 
better wettability than PVP SD. No significant difference was noted in stability except for 
HPMC-AS at 1:1 ratio, where crystallisation was detected in the spray dried formulation. 
The use of Flory-Huggins phase diagrams as a pre-formulation tool for the preparation of 
ASD by HME and spray drying was investigated by Tian(Tian et al., 2014). The method was 
used to forecast drug solubility and miscibility in polymer candidates and the data was used 
to predict outcomes based on manufacturing method. Solid dispersions were prepared by both 
techniques and characterised using a combination of thermogravimetric analysis, DSC, FTIR 
and PXRD. Key findings were that spray drying allowed generation of ASD over a wider 
range of drug loads than HME. Melt extrusion provided enough energy for more efficient 
mixing between drug and polymer, which may improve stability. It was also established that 
stronger drug-polymer interactions could be generated through melt extrusion. Remixing and 
dissolution of recrystallized felodipine into polymer occurred during DSC, but the 
complimentary information from FTIR confirmed that freshly prepared spray dried samples 
were amorphous with the existence of amorphous drug domains in highly loaded samples. 
A comparison of the properties of  binary ASD of felodipine with polymers PVP and HPMC-
AS prepared by hot melt extrusion and spray drying was published by Paradkar and co-
workers(Mahmah et al., 2014). The key findings were that spray dried formulations released 
felodipine faster than melt extruded formulations for both polymer matrices. ASD comprising 
HPMC-AS released higher drug rates and better wettability than those comprising PVP. No 
significant differences in stability were noted except with HPMC-AS at high drug loading 
where crystallisation was detected in spray dried dispersions. 
The influence of preparation method on the surface/bulk structural relaxation and glass 
fragility of ASD of indomethacin with PVP was reported(Ke et al., 2012). Melt quenching, 
ball milling and spray drying were employed as preparation techniques and values in bulk 
and at surface were reported. All samples had higher molecular mobility at the surface than in 
the bulk. The glass fragility was affected by the preparation method with the most fragile 
systems showing the best stability. 
A comparison between spray drying and freeze drying for producing ASD of hydrocortisone 
with PVP was reported(Dontireddy and Crean, 2011). Freeze dried dispersions had faster 
dissolution rates than SDD and this was still the case after samples had been put on stability 
at 40 oC and 75% RH.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
A comparison of spray drying and milling as preparation methods for producing ASD of 
sulfathiazole or sulfadimidine with PVP was reported(Caron et al., 2011). DSC studies 
revealed a single glass transition temperature for sulfathiazole with weight loadings of 0% - 
95% for spray drying and 0% - 40% for milling. Similarly, sulfadimidine weight loadings of 
0 - 100% for spray drying and 0 - 30% for milling produced homogenous glassy solutions. 
The value of Tg did not depend on the production technique. A good overlap was found 
between experimental observations and both Gordon-Taylor equation and Flory-Huggins 
theory. Dissolution was found to increase for co-processed materials relative to physical 
mixtures and results from milling were comparable to spray dried materials. 
NOVEL ANALYTICAL TECHNIQUES 
Powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and polarised 
light microscopy (PLM) have become the gold standard techniques for characterising 
amorphous solid dispersions. However there is a limit to the type of information that can be 
interpreted from these methods and work has been ongoing to develop complimentary means 
for analysing such materials. 
The phase separation of an itraconazole-HPMC amorphous dispersion was recently 
examined using fluorescence at nano and micron levels(Purohit et al., 2017). It was found 
that the rate of solvent evaporation played a key role in the size of the phase separated 
domains, with smaller domains (<10 nm) observed in spray dried dispersions and larger 
domains (>30 nm) in ASD from slower evaporation techniques. Confocal imaging provided 
visual confirmation of the phases while solid state NMR confirmed fluorescence results and 
was used to quantify the size of the domains. 
X-ray microtomography has been assessed as a tool to measure powder characteristics such 
as wall thickness and solid volume fraction for hollow, polymer-stabilised spray dried 
dispersions(Gamble et al., 2016). SDD of various shell wall thickness and degree of particle 
collapse were studied and the morphology was discussed in terms of performance 
characteristics and processing of the bulk powder. Quantitative measurement of wall 
thickness, void volume and solid volume was performed and the impact of drying rate on 
morphology was examined. A deeper knowledge of particle characteristics may lead to a 
better understanding of their impact in downstream processing and final dosage performance. 
Crystallisation behaviour of a ternary SDD of probucol with HPMC and sodium dodecyl 
sulfate was recently studied using atomic force microscopy (AFM)(Egami et al., 2015). The 
ASD was prepared by spray drying and examination by PXRD and solid state NMR showed 
that the dispersion were amorphous. The SDD was then added to water, whereupon 
nanocrystals of 25 nm were observed and this gradually increased to 94 nm upon storage for 
7 days. AFM was employed to directly observe morphology and agglomeration behaviour of 
the nanoparticles in water. Depending on the storage period involved the AFM force-distance 
curves varied from complete indentation at 1 nN through to almost no indentation at 5 nN. 
Stiffness increase in the particles was rationalised by changes from the amorphous to 
crystalline states and these findings were supported by solid-state NMR measurements. 
Transmission electron microscopy (TEM) was utilised as a technique to evaluate the 
crystallinity of SDD comprising griseofulvin and HPMC-AS(Ricarte et al., 2015). The 
advantages of the technique included real-space images, electron diffraction patterns (for 
unambiguous assignment) and ability to detect drug crystals at levels of around 3 % (v/v). 
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Both TEM and wide-angle X-ray scattering (WAXS) detected no crystals present in the 
SDDs, with drug loadings of 5, 10 and 50 % (w/w). However a 5 % annealed sample was 
detected by TEM but not WAXS or DSC, thereby demonstrating the superior sensitivity of 
TEM for detecting crystals. 
Modulated DSC has been combined with surface analysis techniques to study the phase 
behaviour and drug distribution of ternary SDD(Meeus et al., 2015b). For ternary systems, 
DSC alone is insufficient for rigorous analysis of phase behaviour or determination of drug 
distribution within a two-phased matrix. Combination of DSC with time-of-flight mass 
spectrometry and atomic force microscopy provided insights into drug distribution in three 
spray dried formulations with varying API/PLGA/PVP ratios. 
Fluorine-Carbon heteronuclear NMR has been reported as a simple and robust method for 
measuring fluorine-carbon proximities in solid state nuclear magnetic resonance (ssNMR) 
experiments using magic angle spinning (MAS). The method was applied to crystalline drug 
avagacestat, containing two types of fluorine atoms and also to the API-polymer 
dispersion(Abraham and Crull, 2014). Results provided insights into molecular structure, 
aided in assignment of carbon resonances and explored the API-polymer proximities in the 
formulation. The method has an advantage over proton-carbon HETCOR due to the large 
chemical shift dispersion in the fluorine dimension. Fluorine-carbon distances of up to 8 Å 
were probed, providing data on API structure, crystal packing and assignment. The main 
benefit of the method was the information on the close molecular level contact between 
amorphous API and the polymer in the SDD, giving insights into the molecular association 
and the role of the polymer in stability. 
Novel approaches to the use of imaging based tools for characterisation of hollow spray dried 
amorphous particles have been reported by Gamble et al(Gamble et al., 2014). Cryo-SEM is 
a form of electron microscopy where hydrated samples can be prepared using fewer 
preparation steps to standard SEM and is regularly used for biological samples. It was used to 
measure the solid volume fraction and particle density of the powders. Static image analysis 
using the Morphologi G3 characterisation system was conducted to explain both the extent of 
attrition within a series of SDD samples and to measure relative particle wall thickness. The 
rich information from imaging based systems can be used concurrently with other powder 
measurements such as bulk density to better understand their impact on downstream 
processing and final dosage form acceptability. 
NOVEL DISSOLUTION TECHNIQUES 
Permeability and solubility remain the key elements deciding the oral bioavailability of a 
drug(Leuner and Dressman, 2000). The mutual advantage of a solid dispersion approach lies 
in a local increase in the solubility and maximising the surface area of the compound that 
comes into contact with the dissolution medium. Because the drug has no crystal structure in 
an amorphous dispersion, no energy is required to break the lattice prior to dissolution. Once 
the solid solution has dissolved, the drug exists as a supersaturated solution. Furthermore, the 
carrier may act to reduce recrystallisation from the supersaturated solution.  
Spray dried rifaximin (BCS class IV) dispersions were prepared in combination with 
hydrophilic polymers and their supersaturation performance was assessed(Beig et al., 2017). 
During parallel artificial membrane permeability assay (PAMPA) and single-pass rat 
intestinal perfusion (SPIP) models, it was found that the results were highly dependent on the 
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polymer selected. Copovidone/HPC-SL formulations performed best, with supersaturation of 
200 times that of crystalline drug over 20 h. In vivo studies measuring absorption rate 
coefficient (ka) also demonstrated an increase in permeability, so an increase in both 
solubility and permeability was achieved. 
BCS class II drug glipizide was spray dried with excipients HPMC-AS and copovidone S-
630(Lu et al., 2016). These occurred as a single amorphous phase up to 60% drug loading 
according to analysis by PXRD, DSC and SEM. Prolonged supersaturation (up to 180 min) 
and solubility increases (5.2–13.9 fold) were reported relative to crystalline drug. 
Formulations containing HPMC-AS-M and HPMC-AS-H achieved the highest stable 
supersaturation levels. Controlled release tablets comprising SDD also provided sustained 
release over 24 h and combination of HPMC-AS and HPMC in the hydrating matrix showed 
strong suppression of drug recrystallisation. 
Binary spray dried dispersions of nifedipine in carriers HPMC-AS, copovidone and PVP 
were prepared to study their supersaturation efficiency and solubility-permeability 
interplay(Dahan et al., 2013). Parallel artificial membrane permeability assays and single pass 
rat intestinal perfusion models were selected. It was found that maintaining drug 
supersaturation was highly polymer dependent, with HPMC-AS being 20-fold, copovidone 
10-fold and PVP 5-fold higher than crystalline nifedipine. Drug flux from supersaturated 
solutions across the intestine was increased and this was independent of the polymer used. 
The twin advantages of increased apparent solubility and increased drug flux was deemed 
more advantageous than competing solubility approaches (e.g. combination with surfactants, 
cyclodextrins or cosolvents). 
Dahan and co-workers have described a trade-off between the increase in solubility and a 
decrease in permeability when formulating with solubilising excipients to increase the 
solubility of lipophilic drugs(Miller et al., 2012). In order to evade this problem, a spray-dried 
ASD of progesterone and HPMC-AS was prepared and tested. Supersaturation was found to 
be 4-fold higher than untreated drug. Furthermore, apparent permeability did not decrease 
and overall flux was markedly increased when measured in PAMPA or rat models. The work 
demonstrated that amorphous dispersions may have a significant advantage over other 
solubility enhancing approaches. 
Special dissolution techniques 
Microcentrifuge dissolution has been studied as a technique to rapidly assess the performance 
of SDD(Wu et al., 2016). The aim was to provide a better understanding of the supernatant 
after centrifugation. Dispersions comprised of indomethacin and ketoconazole with polymers 
PVP and HPMC-AS. Centrifugation was completed at various speeds and supernatant was 
passed through a series of filters to examine particulate properties. It was found that the 
indomethacin dispersions were more suited to this method than ketoconazole dispersions and 
therefore the use of microcentrifuge dissolution should be selected on a case-by-case basis. 
An in vitro dissolution method that could discriminate for crystalline drug content using 
tablets comprising spray dried evacetrapib was reported by Aburub and co-workers (Pack et 
al., 2017). Dissolution media, paddle speed and surfactant parameters were varied during 
optimisation. Selectivity was tested by spiking tablets with 10, 20 and 30% crystalline drug 
substance, leading to a 13%, 22% and 32% drop in dissolution end point, relative to unspiked 
SDD tablets. Also, tablets were tested in a relative bioavailability study where the dissolution 
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end point of SDD tablets was found to be 4-fold higher than that of tablets with crystalline 
drug. 
Improvements on commercial dosage forms 
There have been several recent publications with direct comparisons to commercial products 
where prototype SDD dosage forms have displayed significantly better dissolution. It should 
be mentioned that relatively few commercial examples of amorphous solid dispersions exist. 
As more and more publications elucidate a deeper knowledge of spray dried dispersions and 
with more than 70% of NCE are classed as poorly soluble, there are likely to be more 
commercial dosage forms in the future. 
Immediate release spray dried formulations of valsartan and Eudragit® E PO were developed 
to enhance delivery in the gastric environment(Pradhan et al., 2016). Significant 
improvements in dissolution rate at pH 1.2 and pH 4.0, compared to both the free drug and 
the commercial product were observed. The amorphous state of the drug was confirmed using 
SEM, DSC and PXRD analysis. 
A spray dried dispersion of ziprasidone and poloxamer 188 was recently incorporated into 
osmotic pump tablets to develop a controlled release strategy with no food effects(Yanfei et 
al., 2015). Various weight ratios were prepared and converted to tablets using wet 
granulation. PXRD and DSC studies showed the SDD to be amorphous and solubility was 
significantly enhanced relative to both non-processed drug and physical mix. Drug release 
profiles in various media showed typical osmotically controlled release and fitted zero-order 
kinetics. Pharmacokinetics during in vivo trials with fasted and fed beagle dogs showed 
prolonged action and no food effect compared to commercial Zeldox®. It was concluded that 
the osmotic pump tablet approach might be suitable to enhance ziprasidone bioavailability in 
the fasted state and also showed sustained release with prolonged actions. 
Commercial new chemical entity (NCE) BMS-B was converted to an amorphous SDD by 
spray drying at 10-25 % (w/w) drug with HPMC-AS(Chen et al., 2014). The SDD were used 
to improve aqueous solubility and study oral toxicology in rats and monkeys. The SDD 
approach was considered possible although challenging due to limitations on wetting and 
dissolution. 
Cui and co-workers have reported the use of spray drying to prepare ASD to improve the 
bioavailability of a B-Raf inhibitor compound G-F(Cui et al., 2013). G-F has poor aqueous 
solubility and is interesting for the treatment of late stage melanoma. Solubility studies of the 
novel ASD indicated an advantage over the crystalline drug form. Both in vitro dissolution 
and in vivo absorption were found to be in good agreement with theoretical solubility 
predictions. 
The solution behaviour of SDD of BMS-A in PVP-VA and HPMC-AS was studied(Qian et 
al., 2012). Both dispersions performed similarly in vitro but the HPMC-AS dispersion was 
significantly better in vivo. This was an excellent example of how polymer selection can have 
a significant in vivo impact that is unrelated to ASD physical stability. 
DOWNSTREAM PROCESSING 
During manufacturing, smooth downstream processing is critically important (Demuth et al., 
2015). Flow into a die or from a hopper can face issues such as bridging, arching or rat-
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holing, leading to production interruptions and incorrect tablet weight. A trade off may be 
required between bioavailability demands of a drug (where smaller PSD is advantageous) and 
flow demands (where larger, spherical particles are more desirable). Granulation with water 
seems like an unnecessary risk, as recrystallisation rates are greatly increased in the presence 
of moisture(Oksanen and Zografi, 1990). Compressibility of some ASD can also be 
challenging, leading to poor tablet quality. Research into win-win solutions is ongoing. 
 
The physiochemical properties of direct compression tablets from spray dried and ball milled  
solid dispersions of tadalafil in vinylpyrrolidone and vinyl acetate block copolymer (PVP-
VA) was studied(Wlodarski et al., 2016). ASD were demonstrated to be amorphous by 
PXRD, DSC and FTIR. All formulations and the crystalline drugs were successfully made 
into directly compressible tablets at doses of 2.5 mg, 10 mg and 20 mg and each lot met the 
requirements of Ph.Eur. The immediate release tablets comprising solid dispersions (IRSDTs) 
had significantly better dissolution profiles to equivalent tablets containing crystalline drug or 
the marketed formulation. 
An unexpected result was recently noted following the post-processing treatment of spray 
dried dispersions of poorly soluble drugs(Chan et al., 2016). Two drugs were spray dried into 
solid dispersions with polyvinyl alcohol then the SD were post-processing treated by 
exposure to 75% RH at room temperature. As expected the percent of crystallinity was 
increased in the post-processing drugs, however, unexpectedly the dissolution efficiencies of 
the post-treated SD systems was higher and more consistent. 
Gliclazide is listed on the WHO list of essential medicines and is also a BCS class II drug. A 
hydrophilic oral controlled release system was developed for this drug by spray drying with 
HPMC-AS or copovidone. Supersaturated dissolution testing indicated prolonged 
supersaturation state and solubility increase of 1.5- to 4.0-fold. Optimised SDD were 
included in matrix tablets with HPMC blends using a compaction simulator. Dissolution 
profiles from matrix tablets were linear with varied dissolution rates. After six month storage 
stability dissolution profiles were stable with similarity factor (f2 = 85). The formulations 
were homogenous (single phase) and HPMC-AS was deemed to be promising for the 
development of matrix systems with HPMC. 
Piroxicam was spray dried both neat and with D-glucosamine HCl in order to enhance the 
dissolution rate(Adebisi et al., 2016). Drug only SDD contained the form II polymorph and 
showed no improvement in solubility but drug-glucosamine (2:1) SDD showed the most 
improved dissolution rate. Electrostatic charges were also studied and it was found that 
piroxicam had a higher tendency to accumulate charge than glucosamine at  −7.5 versus 3.1 
nC/g for spray dried components. A negligible charge density of 0.1–0.3 nC/g was recorded 
for spray dried dispersions, thereby improving handling and dissolution behaviour of the 
drug. 
Compression effects were studied in ASD of miconazole with PVPVA64 made by spray 
drying and hot melt extrusion(Singh et al., 2015). SDD from spray drying initially showed 
two glass transition temperatures, whereas extruded ASD showed a single Tg indicating better 
mixing. Compression led to mixing of SDD at higher pressures and higher dwell times. 
Extruded samples showed no statistical difference on compression, but physical mixtures of 
extruded samples underwent mixing. Coincidence Doppler measurements on the pure 
polymer revealed a small but significant difference dependant on manufacturing technique. 
Plastic deformation and flow induced by compression increases molecular mobility leading to 
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domains in solid dispersions. Different manufacturing methods may lead to products with 
similar free volume and therefore similar molecular mobility. 
Solid dispersions of nifedipine have been prepared and characterised in a Würster coater 
using porous spherical silicate microbeads (100 µm) and polymer PVPVA(Nagane et al., 
2015). Supersaturation was superior to previous studies using microbeads only. Powder 
characteristics were preferable to conventional spray dried dispersions of nifedipine and 
PVPVA, thereby easing downstream manufacturing. 
Nifedipine was spray dried in various weight ratio combination with Soluplus®, an excipient 
polymer usually processed by hot melt extrusion(Soulairol et al., 2015). Powders were 
compacted in tablet form. Addition of the polymer improved the smoothness of the particles 
and reduced crystallinity of the drug in the resultant powder, although phase separation was 
observed at high drug loadings. Compaction with polymer improved cohesiveness of SDD 
and this was confirmed by Heckel modelling. Dissolution kinetics of all spray dried samples 
was improved relative to crystalline drug. 
Compression induced mixing of phase-separated SDD was studied using miconazole-
PVPVA64 as a model system(Singh et al., 2014). At several drug loadings two Tg values 
were observed prior to compression, but one Tg value was seen post compression. This was 
attributed to polymer flow. 
The effect of aqueous or organic solutions of Eudragit RS for the production of sustained 
release microparticles of theophylline using spray drying has been reported(Garekani et al., 
2013). The SD samples were compacted and crushing strengths and release profiles of the 
tablets were determined. Yields were higher for SDaqueous, but SDorganic samples had 
higher crushing strength and better release profiles. 
The effect of different excipients and processing conditions on the stability of SDD of 
ibipinabant was investigated(Leane et al., 2013). The physical stability of tablets with 
different excipients was significant and the best results were obtained using microcrystalline 
cellulose (MCC). Minimising the number of compression steps improved formulation 
stability, with direct compression performing best. Levels of crystallinity were higher in 
coated tablets, probably caused by exposure to moisture and heat.  
Although wet granulation of amorphous systems is risky(Oksanen and Zografi, 1990), wet 
granulation is a standard unit operation in the pharmaceutical industry and most drug product 
plants use this process. The effects of wet granulation on the properties of solid dispersions 
was recently reported by Kinoshita(Kinoshita et al., 2017) with emphasis on physical stability 
and dissolution. Nilvadipine was combined with hypromellose and spray dried before wet 
granulation and drying under variable conditions. Drug concentration at 4 h from dissolution 
tests was used to assess solubility. PXRD patterns were recorded on granules to test physical 
stability during storage at 60 oC over 3 months. Statistical analysis revealed that the amount 
of granulation liquid and the ratio of water to ethanol in the liquid significantly affected 
dissolution properties and that drying temperature significantly affected physical stability. It 
was concluded that the risk of including water in the granulation of an SD could be mitigated 
by selection of lower proportions of liquid, higher ratios of ethanol in the liquid and higher 
drying temperature. 
MECHANISTIC STUDIES OF SUPERSATURATION OR RECRYSTALLISATION 
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By deepening insight into the mechanistic processes involved in supersaturation, dissolution 
and recrystallisation, it will become possible to formulate dosage forms with better 
pharmacokinetic properties. Spectroscopy, in silico studies, mathematical modelling, imaging 
techniques and spectrometry are utilised to gain information at an intimate molecular level. 
Spray dried dispersions of anti-malaria drug artemether were prepared in combination with a 
variety of polymers and physiochemical, dissolution and in silico studies ensued(Pawar et al., 
2016). A reduced crystallinity of SDD relative to neat drug was detected by DSC and PXRD. 
Drug-polymer interactions were studied by docking and molecular dynamics and a van der 
Waals stabilisation was suggested. The best formulation released 82% drug after 60 min and 
all SDD were reported to be stable over ICH timelines and free of crystalline drug. 
The influence of solution-state polymer assemblies on amorphous SDD performance of drugs 
phenytoin and probucol was studied using four model polymer excipients(Dalsin et al., 
2014). Selective and non-selective solvents for the hydrophilic block of the polymers were 
used to induce or repress solution state assemblies prior to spray drying and this was 
monitored using dynamic light scattering (DLS). DLS revealed differences in solution 
assembly, size and structure. Crystallisation temperatures and enthalpies indicated that the 
drugs interacted mostly with the N,N-dimethylacrylamide (DMA) portions of the polymers 
studied. In vitro dissolution tests indicated an excellent performance for one of the systems 
containing probucol. Dissolution studies involving DLS were performed to better understand 
the drug-polymer aggregates. Forced aggregation of polymer into regular micelles was found 
to be a critical factor in increasing both the dissolution rate and the supersaturation 
maintenance. 
An investigation into the mechanisim of crystallisation of spray dried drugs  indapamide, 
metolazone and glibenclamide was recently reported(Edueng et al., 2017). A step-by-step 
experimental protocol employing DSC, DVS, PLM and a small scale dissolution apparatus 
(μDISS Profiler) to investigate the mechanism by which crystallisation occurred in solution. 
An addition of 0.001% - 0.01% (w/v) HPMCP to the dissolution medium successfully 
prevented drug crystallisation from supersaturation in some samples. Molecular dynamic 
simulations of drugs with HPMC suggested that hydrogen bonding could play a greater 
stabilising role in indapamide, compared to glibenclamide. 
The dissolution mechanism of spray dried ASD of felodipine-copovidone was investigated 
using a combination of spectrophotometric, magnetic resonance imaging and mathematical 
modelling techniques(Langham et al., 2012). Both compacted and powdered materials were 
studied revealing that compaction resulted in a strong decrease in both rate and extent of 
release. Lower drug-loadings (5% and 15%) eroded with linear kinetics suggesting matrix 
control, but higher loadings (30%) experienced dissolution dominated by the drug with 
swelling rather than erosion. 
An excellent study on the factors influencing drug release from ASD has recently been 
reported by Chen and co-workers(Chen et al., 2016). Ketoconazole dispersions were prepared 
by spray drying with a range of polymers and these SDD were compared with physical mix 
and polymer-only equivalents by NMR and FTIR techniques. Flory-Huggins interaction 
parameter (𝜒) showed the drug to be miscible with PVP, PVP-VA and HPMC-AS, but poorly 
miscible with HPMC and this was confirmed by spectral data. Overall it was concluded that 
initial drug release from dispersions was controlled by (a) polymer release rate, (b) the 
strength of the drug-polymer interaction, including effects from both inherent chemistry and 
ratio and (c) the level of mixing homogeneity. 
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OTHER ORAL DELIVERY TECHNOLOGIES 
Cubosome precursor microparticles prepared by spray drying and converting to cubosomes in 
situ (on exposure to aqueous media) have recently been reported(Mei et al., 2017). This 
approach may be a solution to storage stability issues frequently encountered using cubosome 
delivery strategies. Docetaxel was chosen as a model drug for dissolution studies and the 
cumulative release was found to be 96% after 120 minutes compared with 75% for the 
physical mix. Drug entrapment efficiency was >95%. 
Spray drying has also been used to produce ASD of metformin hydrochloride for use in 
bioadhesive drug delivery systems for the oral cavity(Sander et al., 2013). 
FUTURE PROSPECTS 
Spray drying is enjoying great popularity in research as a tool for creating particles with 
enhanced bioavailability. Given the high number of drugs experiencing poor solubility it is 
likely that research, development and commercial use of spray drying will continue to 
increase. 
Commercial technology is improving. Advanced rotary atomisers are now available that are 
no longer prone to high maintenance costs(Lonergan, n.d.). A direct drive magnetic spray 
machine (MSM) is now in production(Khatri et al., 2015). Bend research have patented the 
use of a pressure nozzle and diffuser plate for producing pharmaceutical particles with larger 
particle size distribution(Beyerinck et al., 2014). As mentioned in the section on downstream 
processing, this is important for flow, die fill, compression and tablet uniformity. Hovione 
have filed a patent concerning continuous production of particles(Fonseca et al., 2016). High-
temperature spray drying using a flash nozzle has also been patented by Bend 
research(Friesen et al., 2016). Process analytical technologies such as FBRM, turbidimetry, 
viscosimetry, laser diffraction, NIR and mass spectroscopy can reduce timescales for 
production quality control(Burggraeve et al., 2013; Chan et al., 2008). 
Regulatory pressures are likely to drive a move away from toxic solvents, over time. 
Supercritical CO2 technology represents a move away from toxicity, but several issues such 
as solubility need to be addressed for this to become more mainstream. Even ppm levels of 
dichloromethane are undesirable, so ethanol and isopropyl alcohol are more likely to be used 
if they fully solubilise all components(Paudel et al., 2013). An information age consumer is 
also more likely to buy a medicine that can be marketed as ‘greener’ than the consumers of 
yesterday. Such information is becoming increasingly readily available with the continued 
rise in information technology and can be exploited as a marketing tool. 
Future innovations are likely to come from within industrial pharmaceutical research groups, 
but also from parallel industries. Food and cosmetic sectors are fast-paced dynamic 
environments with differing regulatory requirements to pharma. Academia-industry 
collaborations are particularly useful sources of new ideas and academic research is not 
nearly as hampered by regulatory constraints. 
Due to the population of lipophilic drugs populating the pharmaceutical pipeline and the 
preference for oral solid dosage, further breakthroughs are very likely. Future publications are 
likely to focus on many of the areas addressed by this review, particularly in the areas of 
understanding stability, manufacturing, dissolution, pharmacokinetics and downstream 
processing. 
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Graphical abstract 
 
Schematic representation of amorphous solid dispersions (ASD), microparticles, 
nanoparticles, Fixed dose (ASD), Ternary ASD and Self-emulsifying drug delivery systems 
(SEDDS) prepared by spray drying. Active pharmaceutical ingredient (API) 1 and 2, 
surfactant and polymers 1 and 2 are illustrated in the legend. 
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NCE: New chemical entity 
NCMP: Nanocomposite microparticles 
NIR: Near infrared 
NLC: Nanostructure lipid carriers 
NMR: Nuclear magnetic resonance 
PAMPA: Parallel artificial membrane permeability assay 
PEG: Poly ethylene glycol 
PHPMA: Poly(N-(2-hydroxypropyl)methacrylamide) 
PLA: Polylactic acid 
PLGA: poly(lactic-co-glycolic acid) 
PSD: Particle size distribution 
PVP: Poly vinylpyrrolidone 
PVP-VA-64: Vinylpyrrolidone-vinyl acetate 
PXRD: Powder X-ray diffraction 
RH: Relative humidity 
RSM: Response surface methodology 
RSM: Response surface methodology 
SD: Spray drying 
SDD: Spray dried dispersion 
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SDS: Sodium dodecyl sulfate 
SEDDS: Self-emulsifying drug delivery system 
SEM: Scanning electron microscopy 
SEM: Scanning electron microscopy 
SLN: Solid lipid nanoparticles 
SLS: Sodium lauryl sulfate 
SMEDDS: Solid self-microemulsifying drug delivery system 
SPIP: Single-pass rat intestinal perfusion 
TEM: Transition electron microscopy 
TGA: Thermal gravimetric analysis 
USP: United States pharmacopeia 
UV: Ultraviolet 
WAXS: Wide-angle X-ray scattering 
WHO: World health organisation 
XRD: X-ray diffraction 
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